Risk factors for inhibitors in hemophilia A based on RNA‐seq and DNA methylation

BACKGROUND: The development of factor VIII (FVIII) inhibitor is a severe complication during replacement therapy for hemophilia A patients. OBJECTIVES: We investigated the potential risk factors for FVIII inhibitor formation based on genome‐wide RNA‐sequencing and whole‐genome bisulfite sequencing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Lyu, Cuicui, Wang, Wentian, Xue, Feng, Chen, Lingling, Li, Huiyuan, Chi, Ying, Ma, Yueshen, Wu, Runhui, Fang, Yunhai, Zhang, Lei, Yang, Renchi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445143/
https://www.ncbi.nlm.nih.gov/pubmed/36090157
http://dx.doi.org/10.1002/rth2.12794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445143/
https://www.ncbi.nlm.nih.gov/pubmed/36090157
http://dx.doi.org/10.1002/rth2.12794

Ejemplares similares